Cargando…
Ideal benznidazole dose regimen in chronic chagasic patients: a systematic review
The present study aimed to review the existing literature and to evaluate the best dose regimen for benznidazole in adult patients with Chagas disease in the chronic phase. A systematic review was conducted followed by meta-analysis. Searches were performed in four databases, to include studies publ...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto de Medicina Tropical
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384592/ https://www.ncbi.nlm.nih.gov/pubmed/32725057 http://dx.doi.org/10.1590/S1678-9946202062052 |
_version_ | 1783563632466984960 |
---|---|
author | Frade, Virgínia Paula Simões, Nathália Soares Couto, Nayara Ragi Baldoni Sanches, Cristina Oliveira, Cláudia Di Lorenzo |
author_facet | Frade, Virgínia Paula Simões, Nathália Soares Couto, Nayara Ragi Baldoni Sanches, Cristina Oliveira, Cláudia Di Lorenzo |
author_sort | Frade, Virgínia Paula |
collection | PubMed |
description | The present study aimed to review the existing literature and to evaluate the best dose regimen for benznidazole in adult patients with Chagas disease in the chronic phase. A systematic review was conducted followed by meta-analysis. Searches were performed in four databases, to include studies published until May 2019. The descriptors used were: “Chagas disease”, “benznidazole”, “Drug Therapy”, “Pharmacokinetics”, “Dose-response relationship, drug” and “Chronic disease”. The meta-analysis compared studies using the standard dose of 5 mg/kg/day for 30 or 60 days. A total of 608 articles were found, 23 of which were considered eligible for this review and nine were included in the meta-analysis. The studies selected and analyzed were published between 1996 and 2018, with various benznidazole dose regimens, ranging from 2.5 mg/kg/day to 10 mg/kg/day, for 30 to 80 days of treatment. The results pointed to a great diversity of dose regimens, thus there is no consensus on the optimal dose regimen for benznidazole in the chronic phase of Chagas disease. |
format | Online Article Text |
id | pubmed-7384592 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Instituto de Medicina Tropical |
record_format | MEDLINE/PubMed |
spelling | pubmed-73845922020-08-03 Ideal benznidazole dose regimen in chronic chagasic patients: a systematic review Frade, Virgínia Paula Simões, Nathália Soares Couto, Nayara Ragi Baldoni Sanches, Cristina Oliveira, Cláudia Di Lorenzo Rev Inst Med Trop Sao Paulo Review The present study aimed to review the existing literature and to evaluate the best dose regimen for benznidazole in adult patients with Chagas disease in the chronic phase. A systematic review was conducted followed by meta-analysis. Searches were performed in four databases, to include studies published until May 2019. The descriptors used were: “Chagas disease”, “benznidazole”, “Drug Therapy”, “Pharmacokinetics”, “Dose-response relationship, drug” and “Chronic disease”. The meta-analysis compared studies using the standard dose of 5 mg/kg/day for 30 or 60 days. A total of 608 articles were found, 23 of which were considered eligible for this review and nine were included in the meta-analysis. The studies selected and analyzed were published between 1996 and 2018, with various benznidazole dose regimens, ranging from 2.5 mg/kg/day to 10 mg/kg/day, for 30 to 80 days of treatment. The results pointed to a great diversity of dose regimens, thus there is no consensus on the optimal dose regimen for benznidazole in the chronic phase of Chagas disease. Instituto de Medicina Tropical 2020-07-24 /pmc/articles/PMC7384592/ /pubmed/32725057 http://dx.doi.org/10.1590/S1678-9946202062052 Text en https://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Frade, Virgínia Paula Simões, Nathália Soares Couto, Nayara Ragi Baldoni Sanches, Cristina Oliveira, Cláudia Di Lorenzo Ideal benznidazole dose regimen in chronic chagasic patients: a systematic review |
title | Ideal benznidazole dose regimen in chronic chagasic patients: a systematic review |
title_full | Ideal benznidazole dose regimen in chronic chagasic patients: a systematic review |
title_fullStr | Ideal benznidazole dose regimen in chronic chagasic patients: a systematic review |
title_full_unstemmed | Ideal benznidazole dose regimen in chronic chagasic patients: a systematic review |
title_short | Ideal benznidazole dose regimen in chronic chagasic patients: a systematic review |
title_sort | ideal benznidazole dose regimen in chronic chagasic patients: a systematic review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384592/ https://www.ncbi.nlm.nih.gov/pubmed/32725057 http://dx.doi.org/10.1590/S1678-9946202062052 |
work_keys_str_mv | AT fradevirginiapaula idealbenznidazoledoseregimeninchronicchagasicpatientsasystematicreview AT simoesnathaliasoares idealbenznidazoledoseregimeninchronicchagasicpatientsasystematicreview AT coutonayararagibaldoni idealbenznidazoledoseregimeninchronicchagasicpatientsasystematicreview AT sanchescristina idealbenznidazoledoseregimeninchronicchagasicpatientsasystematicreview AT oliveiraclaudiadilorenzo idealbenznidazoledoseregimeninchronicchagasicpatientsasystematicreview |